BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23377669)

  • 41. CD28-specific antibody prevents graft-versus-host disease in mice.
    Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
    J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells.
    Shi Z; Rifa'i M; Lee YH; Shiku H; Isobe K; Suzuki H
    Immunology; 2008 May; 124(1):121-8. PubMed ID: 18205792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
    Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
    Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
    Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
    Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential upregulation of interleukin-18 receptor alpha chain between CD4+ and CD8+ T cells during acute graft-versus-host disease in mice.
    Itoi H; Fujimori Y; Tsutsui H; Matsui K; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
    J Interferon Cytokine Res; 2004 May; 24(5):291-6. PubMed ID: 15153312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
    Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
    J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
    Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
    J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.
    Yu XZ; Albert MH; Martin PJ; Anasetti C
    J Clin Invest; 2004 Jun; 113(11):1624-30. PubMed ID: 15173889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.
    Ni X; Song Q; Cassady K; Deng R; Jin H; Zhang M; Dong H; Forman S; Martin PJ; Chen YZ; Wang J; Zeng D
    J Clin Invest; 2017 May; 127(5):1960-1977. PubMed ID: 28414296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
    Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
    J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute graft-versus-host disease without costimulation via CD28.
    Speiser DE; Bachmann MF; Shahinian A; Mak TW; Ohashi PS
    Transplantation; 1997 Apr; 63(7):1042-4. PubMed ID: 9112366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model.
    Safari Zanjani L; Shapouri R; Dezfulian M; Mahdavi M; Shafiee Ardestani M
    World J Microbiol Biotechnol; 2019 Jun; 35(6):94. PubMed ID: 31187291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation of alloreactive CD8+ T cells toward a regulatory T cell phenotype by a mechanism that is dependent on aryl hydrocarbon receptor in CD4+ T cells.
    Funatake CJ; Marshall NB; Kerkvliet NI
    J Immunotoxicol; 2008 Jan; 5(1):81-91. PubMed ID: 18382861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
    Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
    Front Immunol; 2021; 12():687961. PubMed ID: 34335589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.
    Haspot F; Villemain F; Laflamme G; Coulon F; Olive D; Tiollier J; Soulillou JP; Vanhove B
    Blood; 2002 Mar; 99(6):2228-34. PubMed ID: 11877302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis.
    Sempowski GD; Cross SJ; Heinly CS; Scearce RM; Haynes BF
    J Immunol; 2004 Jan; 172(2):787-94. PubMed ID: 14707048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.